Of the components of the primary outcome , only hospitalization for heart failure had a significantly lower incidence in the spironolactone group than in the placebo group ( @ patients -LSB- @ % -RSB- vs. @ patients -LSB- @ % -RSB- ; hazard ratio , @ ; @ % CI , @ to @ , P = @ ) .